Seres Therapeutics, Inc. Impairment of Long-Lived Assets Held-for-use
Seres Therapeutics, Inc. (MCRB) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2023-12-31, per its 8-K filed 2024-08-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2024-08-15
- Seres Therapeutics, Inc. impairment of long-lived assets held-for-use for the quarter ending 2015-12-31 was $0.00.
- Seres Therapeutics, Inc. impairment of long-lived assets held-for-use for the quarter ending 2015-09-30 was $0.00.
- Seres Therapeutics, Inc. impairment of long-lived assets held-for-use for fiscal 2022 was $0.00.
- Seres Therapeutics, Inc. impairment of long-lived assets held-for-use for fiscal 2021 was $0.00.
- Seres Therapeutics, Inc. impairment of long-lived assets held-for-use for fiscal 2020 was $0.00.
- Seres Therapeutics, Inc. impairment of long-lived assets held-for-use for fiscal 2019 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 8-K · filed 2024-08-15 | |||
| 2022-12-31 | $0.00 10-K · filed 2023-03-07 | |||
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2020-12-31 | $0.00 10-K · filed 2021-03-02 | |||
| 2019-12-31 | $0.00 10-K · filed 2020-03-02 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-03-06 | |||
| 2017-12-31 | $0.00 10-K · filed 2018-03-08 | |||
| 2016-12-31 | $0.00 10-K · filed 2017-03-16 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $0.00 derived: sum of 2 quarters · filed 2016-03-14 | $0.00 10-K · filed 2016-03-14 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |